Davis Polk, Mayer Brown represents Abbott Laboratories on $2.5 billion note offering
Mayer Brown guided Chicago-based Abbott Laboratories in its multi-tiered note offering of $2.5 billion worth of senior notes. The company sold $750 million worth of senior notes with a 2 percent interest rate due 2020 and another $750 million worth of senior notes with a 2.55 percent interest rate due 2022. Abbott also sold $1 billion worth of senior notes with a 2.95 percent interest rate due 2025.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
